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Abstract
Background: Incremental palmar stimulation of the median nerve sensory conduction at the wrist, the “inching
test”, provides an assessment with reference to segments proximal and distal to the entrapment. This study used
high-resolution ultrasonography (US) to measure the median nerve’s cross-section areas (CSAs) like the “inching
test” and to correlate with the nerve conduction study (NCS) severity and duration of carpal tunnel syndrome
(CTS).
Methods: Two hundred and twelve (212) “CTS-hands” from 135 CTS patients and 50 asymptomatic hands
(“A-hands”) from 25 control individuals were enrolled. The median nerve CSAs were measured at the 8-point
marked as i4, i3, i2, i1, w, o1, o2, and 03 in inching test. The NCS severities were classified into six groups based on
motor and sensory responses (i.e., negative, minimal, mild, moderate, severe, and extreme). Results of US studies
were compared in terms of NCS severity and duration of clinical CTS symptoms.
Results: There was significantly larger CSA of the NCS negative group of “CTS-hands” than of “A-hands”. The cut-
off values of the CSAs of the NCS negative CTS group were 12.5 mm2, 11.5 mm2 and 10.1 mm2 at the inlet, wrist
crease, and outlet, respectively. Of the 212 “CTS-hands”, 32 were NCS negative while 40 had minimal, 43 mild, 85
moderate, 10 severe, and two extreme NCS severities. The CSAs of “CTS-hands” positively correlated with different
NCS severities and with the duration of CTS symptoms. By duration of clinical symptoms, 12 of the 212 “CTS-
hands” were in the 1 month group; 82 in >1 month and ≤12 months group, and 118 in >12 months group. In
“inching test”, segments i4-i3 and i3-i2 were the most common “positive-site”. The corresponding CSAs measured
at i4 and i3, but not at i2, were significantly larger than those measured at points that were not “positive-site”.
Conclusions: Using the 8-point measurement of the median nerve CSA from inlet to outlet similar to the “inching
test” has positive correlations with NCS severity and duration of CTS clinical symptoms, and can provide more
information on anatomic changes. Combined NCS and US studies using the 8-point measurement may have a
higher positive rate than NCS alone for diagnosing CTS.
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Background
Carpal tunnel syndrome (CTS) is a common entrapment
neuropathy of the median nerve [1]. Currently, nerve
conduction study (NCS) is used to confirm the diagnosis
and indicate the level of the lesion [2,3]. Among various
NCS methods for evaluating CTS, incremental palmar
stimulation of the median nerve sensory conduction at
the wrist, the so-called “inching test”, permits an assess-
ment with reference to nerve segments proximal and
distal to the entrapment [4]. Aside from NCS, peripheral
nerve ultrasonography (US) is a promising complemen-
tary tool [3,5-9]. However, because of different US
methods, the measured values of the median nerve in
CTS also vary [7-10]. This study introduced an 8-point
measurement of the median nerve’s cross-sectional area
(CSA) from inlet to outlet similar to those performed in
the “inching test”. The measured CSAs were also com-
pared to NCS severity and duration of CTS symptoms.
Methods
This prospective case-control study conducted over a per-
iod of three years (2006-2008) enrolled 160 participants
and 262 hands. Of the 160 participants, 135 with 212
hands had clinical symptoms of CTS (“CTS-hands”) while
the other 25 participants of 50 hands were asymptomatic
(“A-hands”) and acted as controls. Of the 135 sympto-
matic participants, 105 were women and 30 were men,
aged 22-83 years (mean, 52.2 ± 11.7 years). Their body
height ranged from 142 to 177 cm (mean, 158 ± 6.3 cm),
body weight 40 to 86 kg (mean, 60.7 ± 8.7 kg), and body
mass index 17.5 to 35.3 (mean, 24.1 ± 3.4). The basic
information of the controls is listed in Table 1. The term
“A-hands” was defined as a hand with normal NCS find-
ings and not fulfilling any clinical definition of CTS.
In order to avoid other interfering factors, none of the
160 participants had diabetes mellitus, gout, rheumatoid
arthritis, renal or liver disease, abnormal thyroid func-
tion, abnormal serum cortisol level, or elevated serum
anti-nuclear antibody. None of the participants had a
history of previous wrist surgery or fracture, or a history
or clinical evidence of neurologic disorders (e.g. ulnar
neuropathy, radiculopathy, polyneuropathy, myelopathy,
or stroke) that might result in numbness or paresthesia.
Participants with a variant of carpal tunnel, such as
accessory muscles, bifid median nerve, and persistent
median artery were also excluded. None of the female
participants were pregnant at the time of the study. The
hospital’s Ethics Committee approved the study (IRB
100-1390B).
Two physicians (Drs CSF and TNW) previously
trained by musculoskeletal radiologists and with more
than three years of experience in patients with related
disorders, especially those with clinical CTS, performed
the US examinations. The clinical symptoms of each
individual were recorded and the collected data were
fully analyzed.
Clinical definition of “CTS-hands”
In this study, CTS was defined according to the criteria
of the American Academy of Neurology practice para-
meters as follows [11,12]:
1. Paresthesia, pain, swelling, weakness, or clumsi-
ness of the hand provoked or worsened by sleep,
sustained hand or arm position, or repetitive action
of the hand or wrist that is mitigated by a change in
posture or by shaking of the hand;
2. Sensory deficits in the median nerve innervated
regions of the hand;
3. Motor deficit or hypotrophy of the median nerve
innervated thenar muscles; and
4. Positive provocative clinical tests (positive Phalen’s
maneuver and/or Tinel’s sign)
The term “CTS-hand” was defined as criterion 1 and
one or more of criteria 2-4 were fulfilled. For compara-
tive analysis, the duration of CTS symptoms was classi-
fied into three groups, i.e. ≤1 month, >1 and ≤12
months, and > 12 months.
Neuro-physiologic assessment
The NCS was performed for all participants according
to the recommended protocol of the American Associa-
tion of Electrodiagnostic Medicine (AAEM) [2] using a
Table 1 Basic information of the control participants and the patients with NCS negative “CTS” hands
“A-hands” (n = 50) NCS negative “CTS hands” (n = 32) p value
Sex 14 hands in man/36 hands in woman 4 hands in man/28 hands in woman 0.100
Age (yr) 44.2 ± 9.8 (46, 25-68) 48.6 ± 11.9 (49, 27-73) 0.135
BH (cm) 163 ± 7.2 (163, 148-174) 159 ± 6.9 (157.5, 150-177) 0.004*
BW (kg) 61.0 ± 8.1 (60, 46-76) 59.6 ± 10.8 (56, 46-86) 0.282
BMI 22.8 ± 3.0 (22.7, 17.5-28.3) 23.6 ± 4.4 (22.9, 17.5-35.3) 0.711
Abbreviations: A-hands, asymptomatic hands; CTS, carpal tunnel syndrome; NCS, nerve conduction study; BH, body heigh; BW, body weight; BMI, body mass
index; Mean ± standard deviation (Median, minimum-maximus);
*p < 0.01 by Mann-Whitney U test
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Nicolet Viking Select system (Nicolet Biomedical Inc.
Madison, USA). All tests were done in the same room
under similar temperature conditions. Skin temperature
was maintained at ≥32°C. As regards NCS, the onset
latency, amplitude, distance, and velocity of median,
ulnar, and radial motor and sensory nerves were mea-
sured. The comparative tests included: 1) median-ulnar
sensory conduction between the wrist and ring finger, 2)
median sensory nerve conduction comparison between
the wrist and palm, 3) median-radial sensory conduction
between the wrist and thumb, and 4) antidromic sensory
test using 1-cm increments of the median nerve with
the wrist crease as the zero reference point extending
proximally by 3 cm and distally by 4 cm. In total, eight
points (Figure 1) were marked in the subsequent inching
test.
The cut-off points used in the NCS were the following:
1) median nerve distal sensory latency <3.4 ms [13], 2)
median nerve distal motor latency over the thenar <4.2 ms
[13], 3) difference between the median and ulnar nerve
distal sensory latencies <0.4 ms [14], 4) trans-carpal med-
ian motor conduction velocity <40.6 ms [15], and 5) anti-
dromic sensory using 1-cm increments of the median
nerve <0.4 ms [16]. Based on the NCS results, the CTS
hands were categorized into six severity groups [17]: nega-
tive, for normal findings on all tests; minimal, for abnor-
mal segmental or comparative tests only; mild, for
abnormal digit/wrist sensory nerve conduction velocity
and normal distal motor latency; moderate, for abnormal
digit/wrist sensory nerve conduction velocity and abnor-
mal distal motor latency; severe, for absence of sensory
response and abnormal distal motor latency; and extreme,
for the absence of motor and sensory response.
Ultrasound assessment technique
High-resolution US was performed using a scanner with
a 12/5-MHz linear array transducer for the carpal tunnel
study (Philips HDI 5000; Philips Medical Systems,
Bothell, WA, USA) on the same day as the NCS. During
the examination, the patient sat in a comfortable position
facing the examiner, with the measured forearm resting
on the table, the palm supine, and fingers semi-extended
in the neutral position [18]. The median nerve was first
imaged in a longitudinal scan, placing the US probe at
the midline between the radius and ulna with the center
of the probe at the distal wrist crease, to obtain an initial
general overview of the median nerve. This was then
used to assist the examiner in obtaining optimal axial
(cross-sectional) images. The transducer was placed
directly on the patient’s skin with gel.
A transverse scan, keeping the probe directly perpendi-
cular to the long axis of the median nerve in order to
ensure that the area measured indeed reflected CSA, was
then performed to record the CSA (calculated by contin-
ual tracing of the nerve circumference, excluding the
hyper-echoic epineurial rim) and elliptical diameters
(transverse and antero-posterior). Measurements were
conducted from the tunnel inlet of the forearm (i4, i3, i2,
Figure 1 The 8-point for recording in both “inching test” and ultrasonography. The i4, i3, i2, i1 represent levels at 4, 3, 2, and 1 cm distal
to the wrist crease in the inlet of the carpal tunnel; w represents the level of the wrist crease and o1, o2, and o3 represent levels at 1, 2, and 3
cm proximal to the wrist crease in the outlet of the carpal tunnel.
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i1) to the wrist crease (w) and to the tunnel outlet (o1, o2,
o3) (Figure 1).
Statistical analysis
Data were given as mean ± standard deviation. Subse-
quent ANOVA analysis followed by Scheffe’s multiple
comparison procedures were used to calculate the mean
values of CSA among different symptom duration
groups, NCS types, and inching sites. To evaluate differ-
ences in CSA value at the 8-point tested between
asymptomatic and CTS hands in the NCS negative
group, the Mann-Whitney U test was used for compari-
son, as a consequence of limited data. Significance was
set at p < 0.05 in the ANOVA and p < 0.01 in the
Mann-Whitney U tests. The area under the ROC (Recei-
ver Operating Characteristic) curves and the CSA cut-
off-values were calculated for the negative NCS CTS
hands. The Statistical Package for Social Science (SPSS
Inc., version 13.0 for Windows) was used for all statisti-
cal analyses.
Results
Based on the NCS severity classification, 32 of the 212
“CTS-hands” were in the negative group, 40 in the mini-
mal group, 43 in the mild group, 85 in the moderate
group, 10 in the severe group, and two in the extreme
group. If classified according to the duration of clinical
symptoms, 12 of the 212 “CTS-hands” were in the ≤1
month group, 82 in >1 month and ≤12 months group,
and 118 in >12 months group.
Comparison of CSAs at the 8-point of A-hands and NCS
negative CTS-hands
The comparative results revealed significantly larger
CSA of the latter group of hands at six points (i4, i3, i2,
i1, w, and o3). After comparison of the CSAs under the
ROC, the cut-off-values of the significant sites were 12.5
mm2, 11.5 mm2, and 10.1 mm2, respectively (Table 2).
Measured CSAs at the 8-point of CTS-hands with different
NCS severities
The measured CSAs were compared. The NCS negative
group and the mild to extreme NCS severity groups,
except the minimal severity group, showed significantly
larger CSA (Table 3). Because of limited case numbers,
both severe and extreme groups were excluded from
subsequent group comparisons; i.e. only the negative,
minimal, mild, and moderate groups were included for
further analysis. Mean CSAs of these four groups
showed that the mean CSAs increased in accordance to
severity, from negative to moderate (Figures 2 and 3).
Frequent positive sites of the “inching test” and their
correspondence to the sizes of measured CSAs
The “positive-site” was defined as conduction delay
(>0.4 ms) between the interval of the nearby marks in
antidromic sensory test with 1 cm increments of the
median nerve at the 8-point marks (Figure 4). Results
showed that the most common “positive-site” were i4-i3
and i3-i2 (Table 4). The comparative results showed
that CSAs corresponding to the “positive site” at i4-i3
were significantly larger than the CSAs of intervals that
were not “positive-site” (Table 5). The CSAs measured
at i2 did not show significant difference between the
positive and the non-positive sites.
Comparison of CSAs of A-hands with those of CTS-hands
by CTS symptom duration
The comparative results showed that CSAs of the “CTS-
hands” with symptom duration >1 month and ≤12
months, and >12 months were significantly larger than
the CSAs of “A-hands”. The difference between the
CSAs of the “A-hands” and the “CTS-hands” with symp-
tom duration > 1 month was not significant. The “CTS-
hands” with >12 months duration had significantly lar-
ger CSA than the “CTS-hands” with <1 month duration
(Table 6).
Table 2 Comparison of CSAs measured at the 8-point of the A-hands and NCS negative CTS-hands
CSAs p value Cut-off values of CSA Sensitivity Specificity
A-hands (n = 50) NCS negative CTS-hands(n = 32)
i4 11.8 ± 2.4 (11, 8-19) 14.3 ± 4.6 (13, 7-28) 0.003* 12.5 0.688 0.720
i3 11.5 ± 2.3 (11, 8-19) 14.0 ± 4.3 (13, 8-28) 0.001* 12.5 0.688 0.760
i2 10.9 ± 1.9 (11, 8-16) 11.9 ± 2.1 (12, 8-17) 0.033* 11.5 0.563 0.660
I1 10.7 ± 1.7 (10.5, 8-15) 12.2 ± 2.7 (11.1, 7-20) 0.006* 11.1 0.500 0.680
w 10.7 ± 2.0 (10.5, 7-17) 12.2 ± 2.9 (12, 7-22) 0.002* 11.5 0.594 0.760
o1 10.1 ± 2.2 (10, 6-16) 11.0 ± 2.3 (10, 7-16) 0.082 10.5 0.469 0.600
o2 10.2 ± 2.1 (10, 7-17) 10.6 ± 2.0 (10.5, 6-15) 0.164 10.5 0.500 0.600
o3 9.4 ± 1.9 (9, 6-15) 10.6 ± 2.7 (11, 5-17) 0.031* 10.1 0.563 0.740
Abbreviations: CSAs, cross-section areas; A-hands, asymptomatic hands; CTS-hands, carpal tunnel syndrome hands; NCS, nerve conduction study
Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3 Unit of CSA = mm2
*p < 0.05, by Mann-Whitney U test
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Discussion
For CTS evaluation, several kinds of NCS measurement
methods are used for confirmation. As to which measure-
ment method is optimum remains the subject of, long-
term debates [1-6,10-20]. In the meantime, although NCS
in CTS diagnosis is highly specific [2], 10-25% of cases are
unrecognized by classic NCS depending on the disease
severity and the type of NCS technique used [2,21-23].













i4 14.3 ± 4.6 (7-28) 15.4 ± 4.7 (8-30) 17.3 ± 5.3 (8-34)* 19.8 ± 6.8 (8.9-41)* 17.3 ± 8.9 (8-40.8) 15.5 ± 3.5 (13-18)
i3 14.0 ± 4.3 (8-28) 15.0 ± 4.6 (8-27) 16.0 ± 4.6 (8-26) 18.4 ± 5.9 (8.9-42)* 17.3 ± 8.9 (8-40.8) 15.5 ± 3.5 (16-22)
i2 11.9 ± 2.1 (8-17) 12.0 ± 3.0 (7-21) 12.3 ± 2.4 (6-18) 13.8 ± 3.8 (7-29) 13.4 ± 4.7 (8-23.6) 17.0 ± 1.4 (16-18)
i1 12.2 ± 2.7 (7-20) 12.6 ± 3.1 (7-20) 14.8 ± 4.9 (8-28) 15.4 ± 5.0 (7-34.4)* 16.7 ± 6.7(11.1-34.3)* 14.5 ± 7.8 (9-20)
w 12.2 ± 2.9 (7-22) 12.9 ± 3.4 (7-22) 14.6 ± 3.4 (7-23) * 17.5 ± 5.8 (9-40.4)* 16.0 ± 5.7 (8.9-26) 26.5 ± 9.2 (20-33)*
o1 11.0 ± 2.3 (7-16) 12.2 ± 2.8 (8-20.7) 12.9 ± 3.0 (8-20) * 14.3 ± 3.2(8.7-27.4)* 13.9 ± 4.5 (7-20.3) 22.5 ± 4.9 (19-26)*
o2 10.6 ± 2.0 (6-15) 11.6 ± 2.6 (8-21) 12.0 ± 2.2 (8-17) * 12.8 ± 2.7 (7-21.3)* 13.9 ± 3.6 (9-19.9) 17.0 ± 0.0 (17-17)*
o3 10.6 ± 2.7 (5-17) 10.9 ± 2.0 (7-15) 11.2 ± 1.9 (7-15) 11.5 ± 2.5 (6-19) 12.0 ± 2.2 (9-16) 19.0 ± 0.0 (19-19)*
Abbreviations: CSAs, cross-section areas; CTS-hands, carpal tunnel syndrome hands; NCS, nerve conduction study Markers of the 8-point: i4, i3, i2, i1, w, o1, o2,
and o3
Unit of CSA = mm2
*p < 0.01, by Mann-Whitney U test (comparing CSAs of the minimal to extreme groups with the negative group)
Figure 2 Cross-section areas (CSAs) at the 8-point of the 212 carpal tunnel syndrome hands ("CTS-hands”) with different nerve
conduction study (NCS) severities. (A) Comparison of CSAs of the NCS minimal to NCS extreme groups with the CSAs of the NCS negative
group using analysis of variance (ANOVA), followed by Scheffe’s multiple comparison analysis. black triangle denoting the significant difference
between the NCS minimal and NCS moderate groups; black square denoting the significant difference between the NCS negative and NCS
moderate groups; black circle denoting the significant difference at w level between the NCS mild and NCS moderate groups, black diamond
denoting the significant difference at o1 level between the NCS negative and NCS mild groups.
Chen et al. BMC Medical Imaging 2011, 11:22
http://www.biomedcentral.com/1471-2342/11/22
Page 5 of 9
Figure 3 The mean CSAs of “CTS-hands” with different NCS severities.
Figure 4 An example of “positive-site” between i4 and i3 corresponding to the relatively smaller cross-section area (CSA) at i2. The
peak latencies (arrowhead) at i4 and i3 are 1.9 ms and 2.9 ms, respectively, and the difference between them is 1.0 ms, i.e. >0.4 ms. The CSA
measured at i2 (arrow) is smaller than those measured at nearby levels. Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3.
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Thus, “CTS-hands” with a negative NCS poses a diagnos-
tic challenge when using electrophysiologic study alone for
confirmation.
In this study, 15.3% (32/212) of “CTS-hands” are NCS
negative. This incidence rate is consistent with those of pre-
vious reports [2,21-23]. With the 8-point CSA measure-
ment, there are significant differences on several levels
between the “A-hands” and NCS negative “CTS-hands”.
Most of the significant enlargements are located at the inlet
(Table 2). It is known that in patients with a clinical diagno-
sis of CTS, the accuracy of US is similar to that of EMG but
is probably preferable because it is painless, easily accessi-
ble, and favored by patients [24]. The findings of the pre-
sent study further strengthen the importance of the
complementary role of US in confirming the diagnosis of
idiopathic CTS in the NCS negative group. This is also
noted in a study of US correlation of CTS in NCS negative
“CTS-hands” reported by Rahmani et al. [19]. Therefore,
US can be recommended as a useful technique in diagnos-
ing CTS patients when NCS results are not confirmatory in
patients suspected of having median neuropathy. The pre-
sent study also posits the following cut-off values of CSA
for CTS confirmation: 12.5 mm2 at the tunnel inlet, 11.5
mm2 at the wrist crease, and 10.1 mm2 at the tunnel outlet.
Except for the NCS minimal group, all of the other
groups of “CTS-hands” (from mild to extreme) have sig-
nificant differences in CSA measurement when compared
to that of the NCS negative group (Table 3 and Figures 2
and 3) and a positive correlation with the severities of
NCS findings. Although some insignificant enlargements
detected in CSA measurement are shown by inter-group
comparison (Tables 2 and 3), the present study demon-
strates that slower NCS means a larger CSA by US study.
As shown in Table 3 and Figures 2 and 3, CSAs mea-
sured at the 8-point of the NCS minimal group are all lar-
ger than those of the NCS negative group, but this
difference is not statistically significant. This insignificance
can be explained partly by the trivial difference in NCS
and measured CSAs in these two groups of “CTS-hands”.
However, this study does not offer enough evidence to suf-
ficiently explain the difference. Further large-scale study is
needed for better delineation of the US findings between
the NCS negative and NCS minimal groups. Nevertheless,
with a measurement of CSA at the 8-point, US remains an
important complementary tool for confirming clinical
CTS.
As shown in Table 4, the segments between i4 and i3,
and i3 and i2 are the most frequent “positive sites”, and
their respective CSAs are larger than those measured at
“non-positive sites” (Table 5). This suggests a positive cor-
relation in NCS severities and measured areas of CSA in
the CTS study, a correlation also noted in other studies
[10,20,25,26]. The present study (Tables 4 and 5) also
reveals that most of the “positive sites” detected in the
“inching test” involve the distal part (i2-14) of the inlet,
and the CSA measured at i2 is the smallest. These show
that the area around i2 is the most possible site of nerve
entrapment in idiopathic CTS, which may provide addi-
tional guidance for a more precise location for treatment.
As shown in Table 6, there is a positive correlation
between the measured CSA with the symptom duration of
clinical idiopathic CTS such that the longer the duration
of symptoms correlated to larger measured CSA. This
finding has not been previously reported. Nonetheless, US
provides reproducible median nerve measurements [27].
As such, it can be used to assess changes in median nerve
characteristics during follow-up studies of idiopathic CTS.
This study has several limitations. First, although 212
“CTS-hands” were included for examination, further
large-scale study is warranted for a more even distribu-
tion of the case number in the different sub-groups of
“CTS-hands”. Second, the limitations of accuracy in
Table 4 Distributions of the positive sites in inching test of all tested hands
Inching None i4-i3 i3-i2 i2-i1 i1-W W-o1 o1-o2 o2-o3 double Total
N (%) 119 37 (25.9) 55 (38.5) 6 (4.2) 10 (7.0) 8 (5.6) 2 (1.4) 0 (0) 25 (17.4) 262
Markers of the 8-point: i4, i3, i2, i1, W, o1, o2, and o3 “double” means more than two sites existed
Table 5 Comparison of CSAs at the 8-points among the
two most frequent positive sites and the negative site in
the inching test
none (n = 119) i4-i3 (n = 37) i3-i2 (n = 55)
i4 13.9 ± 4.8(7-40.8) 19.5 ± 6.9 (9-37)* 19.0 ± 6.9 (8-41)*
i3 13.6 ± 4.8 (8-40.8) 17.4 ± 5.0 (8-32) * 17.9 ± 6.3 (8-42)*
i2 12.0 ± 3.1 (8-29) 12.4 ± 3.1 (6-19) 13.2 ± 3.4 (8-25)
i1 12.4 ± 4.1 (7-34.4) 13.6 ± 4.5 (7-31) 14.6 ± 4.3 (7.4-25)*
w 12.5 ± 4.0 (7-31) 14.5 ± 4.6 (7-27) 15.6 ± 4.9 (7-33)*
o1 11.3 ± 2.8 (6-20.7) 13.1 ± 2.9 (9-20) 13.6 ± 3.6 (8-26)*
o2 11.0 ± 2.4 (6-18.5) 12.2 ± 2.4 (8-18) 12.8 ± 2.7 (8-21.3)*
o3 10.5 ± 2.6 (5-19) 10.5 ± 2.3 (6-16) 11.8 ± 2.4 (8-19)*
Note: CSA, cross-section area; none, no conductive delay >0.4 ms in median
inching test in centimeter across the carpal tunnel; i4-i3, conductive delay
>0.4 ms in inching test between 4 cm and 3 cm distal to the wrist crease; i3-
i2, conductive delay >0.4 ms in inching test between 3 cm and 2 cm distal to
the wrist crease
Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3
i4-i3 and i3-i2: the difference of latency measured between locations of i4 and
i3, and i3 and i2 in the inching test
Unit of CSA = mm2
*p < 0.05 in comparing the two most frequent positive sites and the negative
one in inching test using analysis of variance (ANOVA) followed by Scheffe’s
multiple comparison procedure
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inching techniques need to be taken into consideration.
This limitation is also noted in other studies [28,29].
Third, there is difficulty in accurately obtaining a chron-
ology of the length of symptom duration. Fourth, there
is a lack of using neuroimaging studies such as com-
puted tomography and/or magnetic resonance imaging
to test the accuracy of CSA measurement at varying
levels and to delineate the local change of carpal tunnel.
Fifth, besides CSA measurement, there are other useful,
additional measurements of the median nerve with US
such as the measurement of width and circumference of
the wrist [30]. In this study we did not perform these
additional measurements for CSA correlation. Lastly,
there is a discrepancy of median nerve length between
the conventional surface measurement and US measure-
ment [31].
Conclusions
More than 15% of “CTS-hands” have negative NCS. The
8-point measurement of the median nerve CSA from
inlet to outlet similar to the “inching test” provides
more information on anatomic changes. This US finding
has positive correlation with NCS severity and the dura-
tion of CTS clinical symptom. A combination of NCS
and US studies, especially the 8-point measurement,
may have a higher positive rate than NCS alone for
diagnosing CTS
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